Anti-fungal drug stops blood vessel growth
...of pharmacology. We couldnt have predicted that an antifungal drug would have such a role. In their search for...y appears online in ACS Chemical Biology. As an antifungal drug, itraconazole blocks a key enzyme for making fungal cholesterol, causing these primitive life f...MacroChem completes patient enrollment for Phase II trial of EcoNail for treatment of onychomycosis
...abel Phase II efficacy study of EcoNail, a topical antifungal lacquer for the treatment of onychomycosis (nail f... the company's patented lacquer which contains the antifungal econazole and MacroChem's enhancer SEPA. Patients participating in the study, which is being condu...'Heroes of Chemistry' honored for medical, green chemistry breakthroughs
...nfections. CANCIDAS is the first of a new class of antifungal agents to reach clinical practice. Unlike its predecessors, the drug specifically prevents the synthesis of an essential component of the cell wall of the most common fungi. The fungicide was initially approved for the treatment of aspergillosis in p...Montreal researchers identify defects of immune cells
...ains of Candida albicans resistant to conventional antifungal therapies. The research project was carried out jointly by Dr. Louis de Repentigny, Director of the Medical Mycology Laboratory and Professor in the Department of Microbiology and Immunology at the Faculty of Medicine of Universit de Montral, and at ...Reports characterize fungal eye infections among soft contact lens wearers
...applied to the eye) or systemic (taken internally) antifungal medication for an average of 67.1 days. Two cases...me between the first symptoms and the beginning of antifungal treatment appeared to be related to treatment outcomes; those patients for whom seven days or more p...Lancet study: Pfizer's Vfend equals two-drug candidemia regimen, with fewer serious side effects
...t in October. The study highlights Vfend, Pfizer's antifungal treatment, as an important treatment option for candidemia in nonneutropenic patients (those who do not have low white blood cell counts). Vfend is the only treatment available in oral and IV formulations that is approved as first-line therapy agains...Mayo Clinic: Sinusitis is common yet often overlooked cause of chronic cough
...ropriate treatment includes the use of prednisone, antifungal sprays or sinus surgery, depending on the severity of the sinus inflammation. Sinusitis also tends to recur. Previously, physicians have often lumped sinusitis and its symptoms together with postnasal drip syndrome from rhinitis as a potential cause ...New analysis supports starting with VFEND for life-threatening fungal infections
...owed that patients who initially received Pfizer's antifungal agent VFEND (voriconazole) were more likely to sur...ch was referred to in the trial as "other licensed antifungal therapy," or OLAT. Treatment was considered successful if the infection improved or was cured after ...Key milestone in antifungal treatment for severe asthma
...have reached a key milestone in their study of the antifungal treatment of asthma. It is hoped that the study,... Previous studies have shown the benefits of one antifungal drug [itraconazole or Sporonox] for the asthma subgroup known as "allergic bronchopulmonary aspergil...One-a-day tablet treats common infection among head and neck cancer patients
A bioadhesive tablet containing the antifungal drug miconazole is an effective and convenient means of treating oropharyngeal candidiasis, which is the most frequently occurring infection in head and neck cancer patients undergoing radiation therapy, scientists report today at the 2nd ESMO Scient...Pfizer's antifungal VFEND provides significant cost advantages when used as initial therapy
... YORK, June 1, 2005 Initial therapy with Pfizer's antifungal treatment, VFEND (voriconazole), IV for injection,...in the June issue of Pharmacotherapy. The overall antifungal drug cost per patient was found to be $961 less for patients who began treatment with VFEND compared...